Awake craniotomy anesthetic management using dexmedetomidine, propofol, and remifentanil
Andrea Prontera, Stefano Baroni, Andrea Marudi, Franco Valzania, Alberto Feletti, Francesca Benuzzi, Elisabetta Bertellini, Giacomo Pavesi, Andrea Prontera, Stefano Baroni, Andrea Marudi, Franco Valzania, Alberto Feletti, Francesca Benuzzi, Elisabetta Bertellini, Giacomo Pavesi
Abstract
Introduction: Awake craniotomy allows continuous monitoring of patients' neurological functions during open surgery. Anesthesiologists have to sedate patients in a way so that they are compliant throughout the whole surgical procedure, nevertheless maintaining adequate analgesia and anxiolysis. Currently, the use of α2-receptor agonist dexmedetomidine as the primary hypnotic-sedative medication is increasing.
Methods: Nine patients undergoing awake craniotomy were treated with refined monitored anesthesia care (MAC) protocol consisting of a combination of local anesthesia without scalp block, low-dose infusion of dexmedetomidine, propofol, and remifentanil, without the need of airways management.
Results: The anesthetic protocol applied in our study has the advantage of decreasing the dose of each drug and thus reducing the occurrence of side effects. All patients had smooth and rapid awakenings. The brain remained relaxed during the entire procedure.
Conclusion: In our experience, this protocol is safe and effective during awake brain surgery. Nevertheless, prospective randomized trials are necessary to confirm the optimal anesthetic technique to be used.
Keywords: anesthesia; awake surgery; dexmedetomidine.
Conflict of interest statement
Disclosure The authors report no conflicts of interest in this work.
References
- Piccioni F, Fanzio M. Management of anesthesia in awake craniotomy. Minerva Anestesiol. 2008;74(7–8):393–408.
- Bharati S, Pal A, Biswas C, Biswas R. Incidence of cardiac arrest increases with the indiscriminate use of dexmedetomidine: a case series and review of published case reports. Acta Anaesthesiol Taiwan. 2011;49(4):165–167.
- Ha SH, Park I-H, Lee M-H, Shi S-K, Min KT. Use of dexmedetomidine for awake craniotomy. Korean J Anesthesiol. 2011;61(4):346–347.
- Erickson KM, Cole DJ. Anesthetic considerations for awake craniotomy for epilepsy and functional neurosurgery. Anesthesiol Clin. 2012;30(2):241–268.
- Rozet I, Muangman S, Vavilala MS, et al. Clinical experience with dexmedetomidine for implantation of deep brain stimulators in Parkinson’s disease. Anesth Analg. 2006;103(5):1224–1228.
- de Almeida AN, Tavares C, Tibano A, Sasaki S, Murata KN, Marino R., Jr Dexmedetomidine for awake craniotomy without laryngeal mask. Arq Neuropsiquiatr. 2005;63(3B):748–750.
- Shen S, Zheng J, Zhang J, et al. Comparison of dexmedetomidine and propofol for conscious sedation in awake craniotomy: a prospective, double-blind, randomized, and controlled clinical trial. Ann Pharmacother. 2013;47(11):1391–1399.
- Mohd Nazaruddin WH, Mohd Fahmi L, Laila AM, Zamzuri I, Abdul Rahman IZ, Hardy MZ. Awake craniotomy: a case series of anaesthetic management using a combination of scalp block, dexmedetomidine and remifentanil in Hospital Universiti Sains Malaysia. Med J Malaysia. 2013;68(1):64–66.
- Kallapur BG, Bhosale R. Use of dexmedetomidine infusion in anaesthesia for awake craniotomy. Indian J Anaesth. 2012;56(4):413–415.
- Chung YH, Park S, Kim WH, Chung IK, Lee JJ. Anesthetic management of awake craniotomy with laryngeal mask airway and dexmedetomidine in risky patients. Korean J Anesthesiol. 2012;63(6):573–575.
- Mack PF, Perrine K, Kobylarz E, Schwartz TH, Lien CA. Dexmedetomidine and neurocognitive testing in awake craniotomy. J Neurosurg Anesthesiol. 2004;16(1):20–25.
Source: PubMed